Welcome to medications.com
NexMed Announces Presentation of Data at the 66th Annual Meeting ... - Business Wire (press release)
NM100060 is a topical application of Lamisil ® (terbinafine hydrochloride), formulated with terbinafine and NexMed’s patented NexACT permeation enhancer, ...
http://www.businesswire.com/porta... |
Posted: Fri Feb 01 10:09:53 -0500 2008
Lamisil Topical RSS FeedADVERTISEMENT
Frequently Reported Side Effects of Lamisil Topical
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com
